SA
Log In
NEULANDLAB.NS
OverviewIntelligenceChart

No data available

Earnings in 9 days · May 12, 2026
Signal
Leaning Bullish1↑1!
Price
1↑
Move↑+1.68%Positive session
Volume
1→
Volume→0.6× avgNormal activity
Technical
1→
Trend↑Rally vs TrendAbove 50D, below 200D
PRICE
Prev Close
14,656.00
Open
14,605.00
Day Range14,464.00 – 15,040.00
14,464.00
15,040.00
52W Range10,578.00 – 19,747.00
10,578.00
19,747.00
47% of range
VOLUME & SIZE
Avg Volume
43.6K
Float
12.8M
FUNDAMENTALS
P/E Ratio
106.8x
Premium valuation
EPS (TTM)
$139.53
Div Yield
No dividend
Quick Read
Earnings in 9d · May 12
Trend
UPTREND
Price above SMA50 & SMA200
Momentum
BULLISH
price above key MAs · revenue +3% YoY
Valuation
EXPENSIVE
P/E 107x vs ~20x sector
Health
MODERATE
CR 2.0 · FCF negative
Strong Buy
Key MetricsTTM
Market Cap$191.19B
Revenue TTM$15.33B
Net Income TTM$1.79B
Free Cash Flow-$2.07B
Gross Margin47.9%
Net Margin11.7%
Operating Margin15.9%
Return on Equity11.8%
Return on Assets7.1%
Debt / Equity0.16
Current Ratio1.96
EPS TTM$139.62
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong3 watch1 concern
58/100
Liquidity
1.96Watch
Leverage
0.16Strong
Coverage
12.8xStrong
ROE
11.8%Watch
ROIC
9.2%Watch
Cash
$1.3BConcern
Analyst Coverage

No analyst coverage available for this stock.

Stock Health
Composite Score
4 of 6 signals bullish
7/10
Trend
●
Trend StateUptrend (price above both MAs)
✓
●
Above SMA 50$13337.16 (+11.7%)
✓
●
Above SMA 200$14564.97 (+2.3%)
✓
Technicals
●
MA AlignmentDeath Cross (50D vs 200D -8.4%)
✗
Fundamentals
●
Last EarningsMissed estimates
✗
●
LiquidityCurrent Ratio 1.96 — healthy liquidity
✓
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Market Position
Price Levels
52W High
$19.7K+32.5%
Current
$14.9K
SMA 200
$14.6K-2.3%
SMA 50
$13.3K-10.5%
52W Low
$10.6K-29.0%
52-Week RangeMid-range
$10.6K47th %ile$19.7K
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 4 analysts
Full estimates →
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$15.7B
$14.9B–$16.5B
—$242.22—
±7%
Low1
FY2025
$15.4B
$15.3B–$15.4B
▼ -1.9%$191.97▼ -20.7%
±7%
Low2
FY2026(current)
$17.6B
$17.0B–$18.1B
▲ +14.6%$200.31▲ +4.3%
±1%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryNEULANDLAB.NS
Last 7Q
-18.3%avg beat
Beat 2 of 7 quartersMissed 5↓ Estimates falling
-15%
Q2'24
+19%
Q3'24
-49%
Q4'24
-51%
Q2'25
+37%
Q4'25
-35%
Q1'26
-35%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Financials
Dividends0.08% yield
+272.8% avg annual growth
Annual Yield0.08%
Annual Div.$12.0000
Est. Annual / Share$12.00
FrequencyAnnual
Q2'19
Q1'20
Q4'20
Q2'21
Q3'22
Q3'23
Q3'24
Q3'25

Dividend per payment — last 8 periods

News & Activity

NEULANDLAB.NS News

20 articles · 4h ago

About

No company information available

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance